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The  procedure  of Perrella et al. (Perrella, M., Ben- 
azzi, L., Cremonesi,  L.,  Vesely, S.,  Viggiano, G., and 
Rossi-Bernardi, L. (1983) J. Biol. Chern. 258,  4511- 
4517) for trapping the intermediate compounds be- 
tween human hemoglobin and carbon monoxide was 
validated  by  quantitatively  determining  during  the  ap- 
proach  to  equilibrium all the  species  present  in  a  solu- 
tion containing large amounts of intermediates. An 
accurate estimate of the intermediate compounds at 
50% carbon  monoxide  saturation  in 0.1 M KCl, pH 7, 
at 22 “C, allowed  the  calculation,  according to Adair’s 
scheme,  of  the  four  equilibrium  constants. 
At 50% ligand  saturation,  the pool  of intermediate 
species was about 12% of  the total. A slightly greater 
concentration of tri-liganded than  mono-liganded spe- 
cies was found.  Carbon  monoxide  bound  to p chains  in 
slightly greater excess with respect  to a chains  in  both 
the mono- and tri-liganded species.  The  symmetrical 
bi-liganded intermediates, a&?O and ag0/9~, were ab- 
sent. The  nature  of  the  bi-liganded  intermediate  found 
to  be  present  in  detectable  amounts  by  our  technique 
has yet to  be  clarified: it could  be either the  asymmet- 
rical species (afl)(acoflco) and ((yaco)(aCofl) or both of 
them.  Such  a  finding  on  the  functional  heterogeneity 
among  the  four  possible  bi-liganded  intermediates is 
consistent with hypotheses of the existence of more 
than two quaternary  structures  in  the  course  of  ligand 
binding to hemoglobin. 
~ 
The molecular mechanism of the cooperative interaction 
between hemoglobin and  its physiological ligands is  still an 
elusive problem in  spite of the vast body of information on 
the  structure  and function of this  protein (1-4). Most of the 
hemoglobin functional  studies have been carried out on either 
liganded and unliganded hemoglobin or on solutions contain- 
ing  these species and unknown amounts of intermediate li- 
gated species. Little  is known about the functional properties 
of such  intermediates. Crystals of deoxyhemoglobin  exposed 
to oxygen and showing only the a chains in liganded state 
have been studied by x-ray methods (5). However, most of 
the crystallographic information available on hemoglobin has 
been obtained from the liganded and unliganded forms. 
The model of allosteric ligand binding to proteins by Monod 
et al. (6), which has been widely applied to  the  interpretation 
of the relationship between the functional and  structural  data 
on hemoglobin, assumes that  the properties of the interme- 
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diate species can be deduced from those of the liganded and 
unliganded species. The model states  that multimeric proteins 
at any stage of the ligation process exist in equilibrium be- 
tween two conformations, T, with low affinity for the ligand, 
and R, with high affinity, and  that  the transition between 
these conformations occurs by some concerted mechanism. 
The conformations of unliganded and liganded hemoglobin 
have been assumed to be, respectively, T and R on  the basis 
of crystallographic and functional studies. A detailed stereo- 
chemical mechanism has been formulated by Perutz to de- 
scribe the concerted conformational transition  in hemoglobin 
(7-9). 
However, thermodynamic studies on the tetramer-dimer 
equilibrium properties of the cyanomet-/deoxyhemoglobin 
hybrids have suggested the existence of more than two ener- 
getic states  in  the course of the stepwise ligand binding to 
hemoglobin (10). High resolution NMR studies on normal 
hemoglobin (ll), on cross-linked valence hemoglobin hybrids 
(12), and on cross-linked asymmetrically modified  hemoglo- 
bins (13) have also suggested the existence of more than two 
structures. 
Clearly, further advancement in the understanding of the 
mechanism of hemoglobin cooperativity is possible only if 
more information is gathered on  the structure  and function 
of the intermediate ligated species. 
A fundamental question regards which species are  present 
under definite equilibrium and  kinetic conditions and in what 
proportions. In principle, the distribution of intermediate 
compounds can be calculated from experimental data on 
hemoglobin-ligand equilibrium isotherms  and from the kinet- 
ics of ligand binding to hemoglobin (14-18). However, these 
indirect  estimates  are critically dependent on the  nature  and 
precision of the experimental techniques, use of sophisticated 
techniques for the numerical analysis of the data,  and exper- 
imental conditions, such as the protein concentration (19). 
Moreover, indirect calculations give no information about the 
functional heterogeneity of the subunits  in hemoglobin. The 
assembly of two different subunits, a and 8, in a tetrameric 
unit allows for the existence of two functionally different 
mono- and tri-liganded species. Since two distinct  intersubu- 
nit contacts, a’@’ and a’$, occur in  the hemoglobin tetramer, 
functional heterogeneity is also possible between the two 
symmetrical bi-liganded species, a& ’ and a!&, and between 
these and the asymmetrical bi-liganded species, (a@)(aLpL) 
and (a@”) ( aLp). 
‘The abbreviations used are: a&$, hemoglobin with a chain in 
deoxy form and P chain  in liganded form, the ligand being CO,  CN-, 
etc., and numerical subscripts  indicating stoichiometry; a;&, hemo- 
globin with a chain in ferric form and @ chain in liganded form; 
(cyB)(&PL), hemoglobin with a’@ dimer in deoxy form and a’@’ dimer 
in liganded form, numerical superscripts indicating the separate 
subunits within the tetramer. 
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8392 Carbon Monoxide  Intermediate  Compounds of Hemoglobin 
Models of hemoglobin function  should  account,  under def- 
inite  conditions, for both  the  proportion of each  intermediate 
species and  the  functional  heterogeneity of the species in  the 
same state of ligation. Thus a direct method for the identifi- 
cation and quantitation of such species would provide an 
essential piece of evidence and  serve the purpose of validating 
proposed  theoretical models. 
In a previous paper we described a technique by which 
intermediate compounds between hemoglobin and carbon 
monoxide are  trapped  by rapidly quenching an  aqueous solu- 
tion of hemoglobin into a cryosolvent at -25 "C containing 
ferricyanide. The valence hybrids  formed  by  oxidation of the 
unliganded hemes of the intermediates are then separated 
from  met-  and carbonylhemoglobin by isoelectric  focusing at 
-25 "C and  identified (20). A significant, although very  small, 
pool of intermediate species, approximately 10% of the total, 
was  found  under  equilibrium  conditions at 20 "C, pH 7, and 
50% carbon monoxide saturation. 
The purpose of this  paper is to give a reliable quantitative 
estimate of the  equilibrium  distribution of intermediate com- 
pounds between hemoglobin and carbon monoxide and to 
answer the question of the functional heterogeneity under 
these conditions of the species in the .same ligation state. 
Thus we report  here new and  definite evidence on  the validity 
of our  procedure  for  trapping  the  intermediates, ba ed on  the 
study of the  approach  to equilibrium in  solutions  containing 
large amounts of intermediates  and  in  reacting mixtures of 
deoxy- and carbonylhemoglobin. We  then  use  the data on  the 
equilibrium concentration of the  intermediates to  predict  the 
carbon monoxide  equilibrium curve of hemoglobin. 
EXPERIMENTAL PROCEDURES 
Quench-fiw  Apparatus-Materials and methods  used  for the iso- 
lation of intermediate  compounds  between  hemoglobin  and  carbon 
monoxide and the apparatus designed to trap the inte.rmediates  under 
Quench-flow  Apparatus 
Driving Ram 
Reaction v 
tube \ 4 
vi-- waste 
hemoglobin 
Oxidized 
sample  for 
IEF at -25' 
Anaeiobic 
plus 
cryosohent 
ferricyanide 
FIG. 1. Diagrammatic representation of the quench-flow 
apparatus  used for trapping  intermediate  compounds  between 
hemoglobin and carbonmonoxide under kinetic conditions. 
The syringes are filled  with  solutions of deoxy- and carbonylhemo- 
globin,  respectively.  Alternatively,  one  syringe  is  filled  with a solution 
of partially oxidized  carbonylhemoglobin and the other  syringe  with 
a solution of dithionite. M is a "ball-mixer" (22) and V is a sampling 
valve through which the reactants are expelled into a cryosolvent at 
-25 "C containing ferricyanide. The cryosolvent is contained in a 
glass  tonometer thermostatted at -25 "C under  anaerobic  conditions 
and is  mechanically  shaken  during  sample  quenching. A sample  of 
quenched reactants is then transferred onto a gel tube for IEF at 
-25 "C. 
kinetic  conditions are described elsewhere (20, 21). Apparatus and 
procedure  are  shown in diagrammatic  form in Fig. 1. Before filling 
the syringes of the quench-flow apparatus with reactants, the dead 
volume  of the syringes and the tubes  connecting the syringes to the 
mixer  were  filled  with 20 mM phosphate  buffer, pH 7.4, containing 
20  mg/ml dithionite and then thoroughly  rinsed  with  reactants. The 
reactants were prepared under anaerobic conditions in glass to- 
nometers. 
Quenching  Medium-Samples  of reactants (0.1  ml)  were  quenched 
into a cryosolvent (0.8 ml)  prepared by diluting in a 1 to 1 ratio 20 
mM phosphate, pH 7.5, at 20 "C, and ethylene glycol. The  concentra- 
tion of  hemoglobin  in the samples  was  4-5 mM (heme  concentration). 
The pH af the cryosolvent  was about 8.5 at -25 "C (23).  Ferricyanide 
was  added to the cryosolvent  in a 10-fold  molar  excess  with  respect 
to the unliganded  heme content of the samples.  When the products 
of the reaction  between  partially  oxidized  carbonylhemoglobin and 
dithionite were quenched, the concentration of ferricyanide in the 
cryosolvent  had to be enough to oxidize  excess dithionite and  also to 
reoxidize the unliganded  hemes of hemoglobin. The optimal  condi- 
tions for these experiments were  checked in preliminary tests using 
solutions of methemoglobin. 
Modified  Quenching  Procedure-Thirty s or 3 min after quenching 
a hemoglobin  sample, the pH of the quenching  medium at -25 "C 
was  raised to 10-11 by the addition of  20-30  pl  of a 0.5 M solution of 
Tris in 50%  ethylene  glycol (v/v). The purpose of such  an  addition 
was to slow  down both the rate of oxidation of the deoxy  hemes  which 
could be formed by CO dissociation (24) and the rate of dimer 
exchange at subzero  temperature  (25). 
We  previously  showed (26) that after removal  of  buffer salts and 
ferricyanide  during the first electrophoretic  phase of IEF at -25 "C 
(5-10 min), the partially oxidized  compounds are stable for the next 
20-25  h.  Before salt removal,  dimer  exchange  reactions  can  occur in
the usual  quenching  medium at -25 "C, as  indicated by the formation 
of about  20%  hybrid in mixtures  containing  equal  amounts of
and either met-  or  carbonylhemoglobin.  Such  hybrid  formation ac- 
counted  for  less than 5% of the total when the modified  quenching 
procedure  was  used. 
Quantitation of the  Quenched  Hemoglobin  Components-This  was 
carried  out after the IEF separation, by scanning at 465 nm color 
slides of the gels in a Cliniscan (Helena Laboratories, Beaumont, 
TX) (20). The accuracy of the method  was tested by  comparing the 
data from the scan of a well  resolved mixture of carbonylhemoglobins 
A0 and C and their hybrid with the concentrations of the same 
components  eluted  from the sliced  gel, as measured  by a micromethod 
for  hemoglobin detection (21). The agreement  was  found to be within 
2% of the total. Instead of using  deconvolution  for the integration of 
the areas  under  overlapping  peaks, we assumed the border  line to be 
at the point of inflexion. This simple,  although  not  rigorous,  proce- 
dure,  reproducibly  measured a value  for the concentration of hemo- 
globin A, in the range of 3.5-4.5% in lysates where the peaks of 
hemoglobins A,, and AI, overlapped. This compares well with the 
average content of hemoglobin AI, in samples of blood from non- 
diabetic  donors  (3.3-3.5%), as measured  by  chromatographic  methods 
Curve  Fitting-Data  on the hemoglobin-carbon  monoxide  equilib- 
rium  were fitted according to Adair's equation  (28)  using the weight- 
ing  procedure of Winslow et al.  (29) and the nonlinear  regression of 
Shrager  (30). 
(27). 
RESULTS 
Isolation of the  Intermediates during Approach to 
Equilibrium 
Quantitative Recovery of the Intermediates-In a previous 
paper (20) we described a test in support of the validity of our 
procedure  for the determination of intermediate compounds. 
It was based  on  the  spectrophotometric  measurement of the 
deoxyhemoglobin content  in  different equilibrium mixtures 
of deoxy- and carbonylhemoglobin and  the methemoglobin 
content in samples of these solutions quenched at subzero 
temperature  in cryosolvent containing ferricyanide. Since  the 
concentration of intermediate  compounds at equilibrium was 
found to be very small,  such a test has  limited sensitivity. To  
test rigorously the accuracy of the  determination of the  inter- 
mediates, the  isolation  and  quantitation  procedures were car- 
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FIG. 2. Densitometer scans of  color slides of gel tubes  used  for  the  separation  by IEF at -25 “C of 
the products  of  quenching a sample  of partially  oxidized carbonylhemoglobin (4 mM heme  concentra- 
tion  in 10 mM phosphate, 0.05 M KCl, pH 7) before  reaction  at 22 “C with  dithionite (a) and after 
reaction  with  dithionite  for  times  varying  from 1.5 to 80 s (b-d). After a 15-min reaction a scan similar 
to d was obtained. Dithionite and ferricyanide were in 20- and 40-fold molar excess, respectively, with respect to 
the hemoglobin concentration. Areas under the peaks, in per cent, and identification of the components to which 
the peaks in scan a refer are as folIows: I, carbonylhemoglobin, 16%; 2, a~ofi+flco, 11%; 4, 27%; 5 ,  
(a’,!3+)(acopco) and (a+p””)(aco@+), 18%; 7, a$@z, 15%; 8, az@+p, 10%; 9, methemoglobin, 3%. The arroms 
indicate the focusing positions of components 3, E, and 6, a+aco@$, which are  present in trace  amounts (<1%). 
The fractions of CO-bound hemes calculated from the scan data are a, 0.64; b, 0.63; c,  0.64; and d, 0.63. 
ried out using a solution containing  a large amount of inter- 
mediates, which was obtained by rapidly mixing at  22 “C a 
solution of carbonylhemoglobin in 0.1 M KCl, pH 7, contain- 
ing 36% methemoglobin, and  a solution of dithionite  in 20 
mM phosphate buffer, pH 7. A sample of reactants was then 
quenched after  times varying from 1.5 s to 15 min. 
Fig. 2a shows a  densitometer  scan of a color slide of a gel 
tube used for the  IEF separation at -25 “C of the species 
present  in the partially oxidized carbonylhemoglobin solution 
before reaction with  dithionite. Five, possibly six, out of the 
eight theoretically predictable valence hybrids (20) are pres- 
ent, each in a concentration equal or greater than 10% of the 
total. The scans in Fig. 2, b d  refer to separations of the 
species formed by quenching samples of this solution after 
reaction with dithionite. 
Under the conditions of this experiment, more than 95% of 
the ferric hemes were reduced to  the ferrous state  in less than 
1 s. Thus the valence hybrids isolated after reacting the 
partially oxidized carbonylhemoglobin solution with dithio- 
nite  for 1.5 and 2.5 s, Fig. 2, b and c, should correspond to  the 
intermediate compounds present in a functional  partially CO- 
saturated solution of deoxyhemoglobin approaching equilib- 
rium with the ligand. Equilibrium was attained  in about 2 
rnin (Fig. 2d). 
The  total fraction of liganded hemes, which can be calcu- 
lated for each  scan  in Fig. 2, b-d knowing the identity of the 
components  and  their relative proportion, remained equal to 
the fraction of CO-bound hemes in the partially oxidized 
hemoglobin solution (0.64 f 0.01). 
Accurate Determination of Small  Amounts of Intermedi- 
ates-Fig. 2d is  representative of the small amount of inter- 
mediates at equilibrium, but  cannot be used for their  accurate 
determination under these conditions unless “blank” cor- 
rected for minor hemoglobin present  in the sample and for 
by-products of the quenching and  separation procedures, such 
as products of slight oxidation of liganded hemes and of 
hybridization reactions at subzero temperature. 
When the approach to equilibrium of rapidly mixed  deoxy- 
and carbonylhemoglobin was studied, as  in Fig. 3, the concen- 
tration of components found after reaction times so short 
that no significant ligand exchange had occurred (31) (Fig. 
3a) was used to correct the concentration of intermediates 
found at equilibrium (Fig. 3d). Thus the small amount of 
intermediates at equilibrium was accurately determined, since 
the same solutions of deoxy- and carbonylhemoglobin were 
used for the equilibrium and  blank run; the blank sample was 
quenched in  the same way as  the equilibrium sample, and 
equilibration of deoxy- and carbonylhemoglobin occurred in 
the reaction tube of the quench-flow apparatus under rigor- 
ously anaerobic conditions before being directly injected into 
the quenching medium. 
Concentration of the  Intermediate Compounds at Equilibrium 
Table I summarizes some of the  data obtained at equilib- 
rium using different hemoglobin preparations, various times 
of equilibration, and different conditions  for the quenching 
reaction. The new data are compared with those from the 
work previously reported (20) (Column a). The agreement 
between the theoretical value of Y = 0.5 and the value 
calculated from the scan percentages was within 1% satura- 
tion (Columns a, b, d, and e). 
Table I also shows the slight changes in  the concentration 
of the intermediates that occurred when the quenched sample 
was exposed to  the oxidant at -25 “C for 1 h before its removal 
by IEF using the normal and  the modified quenching proce- 
dure, which consisted in raising the  pH of the medium after 
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8394 Carbon Monoxide Intermediate Compounds of Hemoglobin 
FIG, 3. Densitometer scans of  color slides of  the  gel  tubes 
used  for  the  separation  by IEF at -25 "C of samples of 1 to 1 
mixtures of deoxy- and  carbonylhemoglobin in 0.1 M KCl, pH 
7, reacted  at 22 O C  for  times  varying from 50 ms to  5 min 
before  quenching. The major peaks, labeled 1 and 9, correspond to 
the focused bands of carbonyl- and methemoglobin, respectively. The 
minor peaks are identified in Table I. 
TABLE I 
Equilibrium per cent concentrations of intermediate compounds 
between carbonmonoxide and hemoglobin (-5 mM) 
in 0.1 M KC1, pH 7, 22 "C at Y = 0.5 
Valence hybrid Intermediate 
Equilibrium % concentration 
a" bb c" dd e' f f  
a2cop2co 44.6  43.6  35.0  42.0  43.5  42.3 
azcoppco 2.5  2.5 2.0 3.8 1.1 1.8 
aEO& 
aacop2co 3.8  3.6 6.2 4.5 4.2 4.3
(aP)(aCOPCO) 
(afl0)(aCop) 0.8 1.0 4.8  0.3 0.6 0.2 
aOlcop2 1.6 0.8  2.2  2.0  2.2  1.6 
a282C0 
a&PcO 3.7  2.7  6.7  3.3  3.2  5.7 
azo2 43.2  45.6 43.1 44.1  45.2  4 .2 
Y %# 50.8  49.6  45.8  49.7  49.1  48.8 
Data from published work (20). 
Same as ', quenched hemoglobin sample left a t  -25°C in presence 
of ferricyanide for 1 h before IEF. 
Tris buffer in 50% ethylene glycol (v/v) (30 pl) was added to  the 
Same as *, 3 min after quenching the hemoglobin sample 0.5 M 
cryosolvent. 
e Deoxy- and carbonylhemoglobin equilibrated for 10 min, same 
quenching procedure as '. 
'Same as e, quenched sample left a t  -25°C in presence of ferri- 
cyanide for 1 h before IEF. 
' Deoxy- and carbonylhemoglobin equilibrated for 5 min. 
Ligand per cent  saturation calculated from scan  data. 
quenching (see "Experimental Procedures"). Clearly, the de- 
crease in  the value of Y% (where Y is hemoglobin fractional 
saturation with ligand) (Column c) was indicative of some 
oxidation of CO-bound hemes, and  the increase in  the amount 
of component 5 (Column c) was likely due to some hybridi- 
zation between met- and carbonylhemoglobin. These side 
reactions were inhibited when the modified procedure was 
used (Column f). However, since ferricyanide removal by IEF 
required only 5-10 min (ZO), both procedures were equivalent 
when overexposure of the sample to the oxidant was avoided. 
The Equilibrium  Curve of Hemoglobin and Carbon Monoxide 
According to  Adair's classical scheme (28) the equilibrium 
between hemoglobin and  its gaseous ligands is described by 
four constants (where K4i (i = 1-4) are equilibrium con- 
stants for binding the  ith ligand molecule). These  are usually 
calculated from the  data on the ligand saturation of hemoglo- 
bin at known free ligand concentrations, since the  constants 
K4i are  related to  the coefficients ai of the following general 
form of Adair's equation (28), which is fitted to such  data by 
numerical methods. 
TABLE I1 
Equilibrium constants (KiJ and Hill coefficient (n) for the reaction of 
human hemoglobin with carbon  monoxide  and oxygen at pH 7 
and 22 "C 
(KLi)d (KA)o2' 
G I "  0.027  (0.035) 0.11 
Ki2' 0.09  (0.16)  0.07 
Ki3= 14 (8.0) 1.5 
Ki4' 26 (21) 85 
n 3.5  (3.4)  2.8 
a Constants referred to unitary ligand concentration at Y = 0.5. 
Assuming [CO] = 5.6 lo-' M at Y = 0.5, Kii = K4i M" X 5.6 lo-' M. 
* Values calculated from averaged data on the concentration of CO 
intermediates at Y = 0.5, as obtained in  this work. Values in  paren- 
theses were recalculated assuming a 100% increment in the concen- 
tration of bi-liganded species and 50% increments  in the concentra- 
tions of the mono- and tri-liganded species at Y = 0.5 with respect to 
the averaged data. 
'Values calculated from the oxygen-binding isotherm at  21.5 "C 
and  the median ligand concentration, as measured by Chu et al. (16). 
CCOJ X 10-8 M 
FIG. 4. Carbon  monoxide  equilibrium  curve  of  human 
hemoglobin. Full line, curve fitted according to Equation 1 to 
equilibrium data of 2.34 M hemoglobin in 0.1 M phosphate, pH 
7,25 "C, adapted from Anderson and Antonini (33), who measured a 
value of n = 2.5. The concentration of CO corresponding to Y = 0.5 
was 5.6 lo-' M. Dashed line, curve calculated using the averaged data 
on the intermediate  concentration  in 5 mM hemoglobin, 0.1 M KC1, 
pH 7, 22 "C, at Y = 0.5. The value calculated for n was 3.5. The 
equilibrium constants for the calculation of the coefficients ai in 
Equation 1 are shown in Table 11. The curve corresponding to  the 
constants shown in  parentheses  in  Table I1  was not  plotted because 
it differs from the dashed line by less than 1% CO saturation. 
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Y =  a$ + 2azp2 + 3a3p3 + 4a,p4 4(1+ alp + a@* + asp3 + ag*)  
The  constants K4i can also be calculated from the concen- 
tration of the intermediates at any value of the ligand satu- 
ration (32). We assumed here that heterogeneity between the 
mono- and  tri-liganded species (Table I) was  negligible, and 
that  the free ligand concentration at  Y = 0.5 was the same as 
that determined by Anderson and Antonini (33) in their study 
of the carbon monoxide equilibrium curve of hemoglobin 
under comparable conditions of pH  and temperature. Calcu- 
lations were carried  out using the averaged data on the con- 
centration of the intermediates  as  obtained  in  this work, and 
their values corrected for some estimated errors. The con- 
stants K'4i, shown in  Table 11, refer to unitary ligand concen- 
tration at Y = 0.5 for the purpose of comparison with the 
data obtained by Chu et al. (16) in  their study of the hemo- 
globin equilibrium with oxygen under comparable conditions. 
Fig. 4 shows the  data adapted from Anderson and  Antonini 
(33) and fitted according to Equation 1, together with the 
curve predicted using the experimental data on the interme- 
diate  concentration. This curve agreed within 1% CO satu- 
ration with the curve corresponding to  the constants shown 
in parentheses in Table 11, which were calculated assuming a 
100% increment  in the concentration of the bi-liganded spe- 
cies and 50% increments in  the concentrations of the mono- 
and tri-liganded species a t  Y = 0.5 with respect to  the averaged 
data. 
DISCUSSION 
O u r  procedure for trapping the intermediate compounds 
between hemoglobin and carbon monoxide is not entirely a 
direct method, since it  is  not  the intermediates but  the prod- 
ucts of their chemical quenching that  are separated by low 
temperature focusing. However, the study reported here on 
the determination of the intermediates  during the approach 
to equilibrium proves the quantitative correlation between 
the original intermediates  and the valence hybrids isolated by 
focusing. In fact, changes in  the  patterns shown in Fig. 2, b 
and c  with respect to  the  pattern  in Fig. 2a were due to  the 
ligand binding reactions  in the course of approach to equilib- 
rium. All  five, possibly six, intermediate compounds formed 
by dithionite reduction of the corresponding valence hybrids 
(i.e. a2@PC0, azEo, aaCo@Fo, aF0@@'O, (a@) ( aC0@'O), and (a@'') 
(aco@) were trapped and quantitatively determined within 
the experimental  error of the technique (*1% of the  total), 
since the  total fraction of liganded hemes remained constant 
throughout the equilibrium process. The scan in Fig. 2d is 
indeed representative of the low amount of intermediate spe- 
cies a t  equilibrium. Thus  the similar finding at  Y = 0.5, when 
the equilibrium is approached by reacting solutions of deoxy- 
and carbonylhemoglobin (Fig. 3), becomes validated. 
We can now turn  to comment on the  nature  and significance 
of the intermediate compounds observed under equilibrium 
conditions at  pH 7, 22 "C, and 50% CO saturation. 
More carbon monoxide bound to  the /3 than  to  the a chains 
in both the mono- and tri-liganded species. Since such a 
heterogeneity was slight and  the  amount of intermediates was 
also small, it  is  not surprising that Davis et al. (34) could not 
find evidence of heterogeneity using high resolution NMR 
techniques. 
A  greater  amount of tri-liganded than mono-liganded com- 
pounds was found. Thus, at Y = 0.5, the concentration of 
deoxyhemoglobin slightly exceeded that of carbonylhemoglo- 
bin. The exact nature of the bi-liganded intermediate found 
to be present in detectable amounts  is unknown. Our work 
indicates that only two out of the four possible bi-liganded 
intermediates have to be taken in consideration, namely 
(a@) ( a''@'') and/or (ape) (aco@). 
Huestis  and  Raftery (35) used '9 NMR to study the equi- 
librium between carbon monoxide and a trifluoroacetonyl 
derivative of hemoglobin. At  near 50% ligand saturation,  they 
observed the presence of two main intermediate compounds 
accounting for  about 12% of the hemoglobin in solution, which 
were identifed as (4%) and a$O@@co (8%). Our work is 
in agreement with their finding that  the tri-liganded species 
are more abundant  than  the mono-liganded species at Y = 
0.5. The identification of the tri-liganded species as a$0p/3co 
claimed by these  authors was the result of their identification 
of as  the bi-liganded species. The basis for such an 
identification was the observation that  the addition of 2,3- 
diphosphoglycerate induced chemical shifts in the same direc- 
tion on the NMR resonances of the bi-liganded intermediate 
and of the cyanomet hybrid a2'CN-& However, it cannot 
be excluded that a  similar effect could be induced by 2,3-di- 
phosphoglycerate on  the resonance of (a/3)(aCoflCo) or
(a@co)  (aco@), which may have been the  true intermediates 
observed by Huestis  and  Raftery (35). The methodology of 
these  authors, which has been questioned by Reisberg et al. 
(36), is more likely to be suitable to identify the conformations 
of the intermediates, whereas the  data reported here, once the 
quantitative correlation between the intermediates  and the 
valence hybrids separated at subzero temperature  are  estab- 
lished, are based on  the physical isolation and identification 
of the intermediates. 
The carbon monoxide equilibrium curve of hemoglobin 
calculated from the concentration of intermediate compounds 
at Y = 0.5 predicted a highly cooperative system since n = 
3.5. Such a prediction was not significantly affected by an 
estimated 50-100% error in the measurement of the concen- 
tration of some or all the intermediates. The uncertainty  in 
the predicted curve introduced by such an error was less than 
the uncertainty in curve fitting the equilibrium saturation 
data due to errors  in the measurements by current techniques. 
This strongly supports our method for determining  both the 
intermediate concentration and the true equilibrium con- 
stants according to Adair's scheme (28). However, the pre- 
dicted curve requires confirmation by measurements of the 
CO equilibrium of hemoglobin other  than those reported by 
Anderson and Antonini (33), who used dilute hemoglobin, 
since under  these conditions a large fraction of the protein is 
present as uncooperative dimers (19). 
Quantitative  testing of models of hemoglobin function have 
made use of the available data on the oxygen-hemoglobin 
equilibrium under various conditions of pH  and temperature. 
The determination of the concentration of the intermediates 
under  these conditions by our technique, if at all possible, 
would require extensive technological modifications. Our find- 
ing that  the bi-liganded species were the least abundant at Y 
= 0.5 agrees with the prediction made by Chu et al. (16) for 
the hemoglobin-oxygen equilibrium. It is also consistent with 
the predictions of several models, such as  that of Monod et 
al. (6) and  the Szabo and  Karplus model (37). 
The functional difference between a and f l  chains  in hemo- 
globin is usually discussed in studies of hemoglobin interac- 
tion with ligands. However, the possibility that  the properties 
of the symmetrical and asymmetrical bi-liganded species may 
differ has been specifically considered only recently (38). 
Functional  and  NMR  studies have been carried out on the 
symmetrical cyanomet-/deoxyhemoglobin hybrids a2gCN- 
and (2). It has been suggested that these molecules 
exist  in  a conformational equilibrium, which, in  the absence 
of organic phosphates,  is essentially shifted toward the con- 
formation of fully liganded hemoglobin. Miura and Ho (12) 
 at Università degli studi di M
ilano, on January 11, 2010
www.jbc.org
Downloaded from
 
8396 Carbon Monoxide  Intermediate  Compounds of Hemoglobin 
have found that  the asymmetrical cyanomet-/deoxyhemoglo- 
bin hybrids stabilized by cross-linking have NMR properties 
different from those of the symmetrical species. Differences 
in  the energetic properties between the bi-liganded symmet- 
rical and asymmetrical cyanomet-/deoxyhemoglobin hybrids 
have been reported by Smith  and Ackers (10). Our finding 
that, under equilibrium conditions with CO, only the asym- 
metrical molecules are detectable among the bi-liganded spe- 
cies shows that  the functional differences between such sym- 
metrical and asymmetrical species exist also in chemically 
unmodified hemoglobin. Such  a finding does not confirm that 
the hypothesis made by Smith  and Ackers (10) and by Miura 
and Ho (12) on the existence of more than two energetic 
states or structures  in the hemoglobin oxygen binding process 
is correct, but is consistent  with  it. 
Our study of the equilibrium of hemoglobin with carbon 
monoxide at  pH 7 and 22 "C was  focused on  a single value of 
the ligand saturation because at Y = 0.5 the accuracy and 
reproducibility of the measurements were found to be maxi- 
mal. It would be worth extending the analysis to other con- 
ditions if such measurements could be supplemented with 
experimental data on the equilibrium between CO and hemo- 
globin similar to those now available on  the oxygen-hemoglo- 
bin equilibria. This would significantly improve the efficacy 
of models in  the elucidation of the mechanisms of cooperative 
ligand binding to hemoglobin, since we have shown here that 
two basic features of such an interaction, the quantitative 
distribution of the intermediates and  the functional hetero- 
geneity of the species, can be clarified by our approach. 
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